Tevogen, Inc. (TVGN)

7.30 -0.06 (-0.82%) USD  |  NASDAQ  |  Sep 14, 09:51
More

Tevogen Price to Book Value

Price to Book Value Chart

View Price to Book Value for TVGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2022. Start Trial.
Date Value
December 29, 2023 17.88
December 28, 2023 17.83
December 27, 2023 17.75
December 26, 2023 17.75
December 22, 2023 17.75
December 21, 2023 17.75
December 20, 2023 17.75
December 19, 2023 17.75
December 18, 2023 17.68
December 15, 2023 17.68
December 14, 2023 17.68
December 13, 2023 17.68
December 12, 2023 17.68
December 11, 2023 17.68
December 08, 2023 17.68
December 07, 2023 17.73
December 06, 2023 17.70
December 05, 2023 17.68
December 04, 2023 17.69
December 01, 2023 17.72
November 30, 2023 17.73
November 29, 2023 17.73
November 28, 2023 17.72
November 27, 2023 17.68
November 24, 2023 17.65
Date Value
November 22, 2023 17.65
November 21, 2023 17.60
November 20, 2023 17.60
November 17, 2023 17.60
November 16, 2023 17.60
November 15, 2023 17.60
November 14, 2023 17.51
November 13, 2023 17.51
November 10, 2023 17.51
November 09, 2023 17.51
November 08, 2023 17.51
November 07, 2023 17.51
November 06, 2023 17.47
November 03, 2023 17.46
November 02, 2023 17.46
November 01, 2023 17.46
October 31, 2023 17.46
October 30, 2023 17.46
October 27, 2023 17.46
October 26, 2023 17.46
October 25, 2023 17.46
October 24, 2023 17.46
October 23, 2023 17.46
October 20, 2023 17.49
October 19, 2023 17.43

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. 25.21
Oncolytics Biotech, Inc. --
Sangamo Therapeutics, Inc. --
Sarepta Therapeutics, Inc. 1.465
Anixa Biosciences, Inc. 6.692

Price to Book Value Related Metrics

PEG Ratio -0.0330
Price 7.30
Earnings Yield -79.88%
Market Cap 31.06M
PEGY Ratio -0.0330